Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia
Quang Le, Jonathan J. Lyons, Andrea Naranjo, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 10, pp. 2348-2361
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1
Jonathan J. Lyons, Jack Chovanec, Michael P. O’Connell, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 2, pp. 622-632
Closed Access | Times Cited: 170
Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation
Thomas Plum, Xi Wang, Mandy Rettel, et al.
Immunity (2020) Vol. 52, Iss. 2, pp. 404-416.e5
Open Access | Times Cited: 152
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Joakim S. Dahlin, Marcus Maurer, Dean D. Metcalfe, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 83-99
Open Access | Times Cited: 112
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Blood (2020) Vol. 137, Iss. 2, pp. 238-247
Open Access | Times Cited: 137
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Henry R. Maun, Janet Jackman, David F. Choy, et al.
Cell (2019) Vol. 179, Iss. 2, pp. 417-431.e19
Open Access | Times Cited: 89
Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression
Rebecca C. Robey, Amy Wilcock, Hope Bonin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 10, pp. 3549-3556
Closed Access | Times Cited: 89
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
Catherine R. Weiler, K. Frank Austen, Cem Akin, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 883-896
Open Access | Times Cited: 86
Diagnosis of mast cell activation syndrome: a global “consensus-2”
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, et al.
Diagnosis (2020) Vol. 8, Iss. 2, pp. 137-152
Open Access | Times Cited: 81
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis
Joana Vitte, Vito Sabato, Charles Tacquard, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 8, pp. 2994-3005
Open Access | Times Cited: 61
Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond
Joana Vitte, Shamila Vibhushan, Manuela Bratti, et al.
Medical Principles and Practice (2022) Vol. 31, Iss. 6, pp. 501-515
Open Access | Times Cited: 42
Selected recent advances in understanding the role of human mast cells in health and disease
Francesca Levi‐Schaffer, Bernhard F. Gibbs, Jenny Hallgren, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1833-1844
Closed Access | Times Cited: 39
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology (2022) Vol. 183, Iss. 7, pp. 693-705
Open Access | Times Cited: 39
Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation
Ernesto Aitella, Ciro Romano, Lia Ginaldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 927-927
Open Access | Times Cited: 1
Primary Atopic Disorders
Joshua D. Milner
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 785-808
Open Access | Times Cited: 60
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 11, pp. 3918-3928
Open Access | Times Cited: 50
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia
Kathleen Luskin, Andrew A. White, Jonathan J. Lyons
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2235-2242
Closed Access | Times Cited: 46
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions
Jonathan J. Lyons, Georg Greiner, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1964-1973
Open Access | Times Cited: 28
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment
George Ν. Konstantinou, Marc A. Riedl, Peter Valent, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 94-106
Closed Access | Times Cited: 21
Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis
Mark Kačar, Matija Rijavec, Julij Šelb, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 4, pp. 392-404
Open Access | Times Cited: 21
The Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases
Ewelina Woźniak, Agnieszka Owczarczyk‐Saczonek, Magdalena Lange, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7021-7021
Open Access | Times Cited: 19
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Roberta Parente, Valentina Giudice, Chiara Cardamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7071-7071
Open Access | Times Cited: 17
Degranulation of Mast Cells as a Target for Drug Development
Bo‐Gie Yang, A-Ram Kim, Dajeong Lee, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1506-1506
Open Access | Times Cited: 17
Paediatric perioperative hypersensitivity: the performance of the current consensus formula and the effect of uneventful anaesthesia on serum tryptase
Nils Vlaeminck, Marie‐Line M. van der Poorten, Cecilie N. Madsen, et al.
BJA Open (2024) Vol. 9, pp. 100254-100254
Open Access | Times Cited: 7
High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need Hymenoptera venom immunotherapy
Peter Korošec, Gunter J. Sturm, Jonathan J. Lyons, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2458-2469
Open Access | Times Cited: 7
Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated Reactions
Hannah Shin, Jonathan J. Lyons
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 4, pp. 199-209
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top